{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:31:44Z","timestamp":1785760304262,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10072-025-08125-7","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:08:23Z","timestamp":1743390503000},"page":"3839-3849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world data"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8465-4460","authenticated-orcid":false,"given":"Emilio","family":"Albamonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrea","family":"Lizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Coratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Mongini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Patanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sframeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Dosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Scarpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Brolatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Zanolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bravetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Pera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio Maria","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Ada","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ItaSMAc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ucci","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Minacapilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veria","family":"Vecchiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Magnolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Sacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ticci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Catteruccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Berardinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Picillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bitetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Capece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Agosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Previtali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Salmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Zanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Zuccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"1","key":"8125_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS (2022) Spinal muscular atrophy. Nat Rev Dis Primers 8(1):52. https:\/\/doi.org\/10.1038\/s41572-022-00380-8","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"8125_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073807305673","volume":"22","author":"BS Russman","year":"2007","unstructured":"Russman BS (2007) Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol 22(8):946\u2013951. https:\/\/doi.org\/10.1177\/0883073807305673","journal-title":"J Child Neurol"},{"issue":"15","key":"8125_CR3","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.3390\/ijms22157896","volume":"22","author":"MER Butchbach","year":"2021","unstructured":"Butchbach MER (2021) Genomic variability in the survival motor neuron genes (SMN1 and SMN2): implications for spinal muscular atrophy phenotype and therapeutics development. Int J Mol Sci 22(15):7896. https:\/\/doi.org\/10.3390\/ijms22157896","journal-title":"Int J Mol Sci"},{"issue":"10","key":"8125_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/DNND.S246907","volume":"15","author":"M J\u0119drzejowska","year":"2020","unstructured":"J\u0119drzejowska M (2020) Advances in newborn screening and presymptomatic diagnosis of spinal muscular atrophy. Degener Neurol Neuromuscul Dis 15(10):39\u201347. https:\/\/doi.org\/10.2147\/DNND.S246907","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"8125_CR5","doi-asserted-by":"publisher","unstructured":"Hoy SM (2021) Nusinersen: a review in 5q spinal muscular atrophy. CNS Drugs 35(12):1317\u20131328. https:\/\/doi.org\/10.1007\/s40263-021-00878-x. Epub 2021 Nov 30. Erratum in: CNS Drugs. 2022 Jan;36(1):99. PMID: 34850360; PMCID: PMC8709816.","DOI":"10.1007\/s40263-021-00878-x"},{"issue":"9","key":"8125_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s40263-022-00941-1","volume":"36","author":"HA Blair","year":"2022","unstructured":"Blair HA (2022) Onasemnogene abeparvovec: a review in spinal muscular atrophy. CNS Drugs 36(9):995\u20131005. https:\/\/doi.org\/10.1007\/s40263-022-00941-1","journal-title":"CNS Drugs"},{"issue":"4","key":"8125_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","volume":"20","author":"JW Day","year":"2021","unstructured":"Day JW, Finkel RS, Chiriboga CA et al (2021) Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol 20(4):284\u2013293. https:\/\/doi.org\/10.1016\/S1474-4422(21)00001-6","journal-title":"Lancet Neurol"},{"issue":"18","key":"8125_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, ENDEAR Study Group et al (2017) Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. N Engl J Med. 377(18):1723\u20131732. https:\/\/doi.org\/10.1056\/NEJMoa1702752","journal-title":"N Engl J Med."},{"issue":"4","key":"8125_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40263-022-00910-","volume":"36","author":"J Paik","year":"2022","unstructured":"Paik J (2022) Risdiplam: a review in spinal muscular atrophy. CNS Drugs 36(4):401\u2013410. https:\/\/doi.org\/10.1007\/s40263-022-00910-","journal-title":"CNS Drugs"},{"key":"8125_CR10","doi-asserted-by":"publisher","unstructured":"Hahn A, G\u00fcnther R, Ludolph A, Schwartz O, Trollmann R, Weydt P, Weiler M, Neuland K, Schwaderer MS, Hagenacker T; Risdiplam Compassionate Use Program Group (2022) Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany. Orphanet J Rare Dis. 17(1):276. https:\/\/doi.org\/10.1186\/s13023-022-02420-8. Erratum in: Orphanet J Rare Dis. 2022 Oct 25;17(1):387. https:\/\/doi.org\/10.1186\/s13023-022-02548-7. PMID: 35854272; PMCID: PMC9295446","DOI":"10.1186\/s13023-022-02420-8"},{"issue":"2","key":"8125_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JND-230162","volume":"11","author":"N Cornell","year":"2024","unstructured":"Cornell N, Childs AM, Wraige E, Munot P, Ambegaonkar G, Chow G, Hughes I, Illingworth M, Majumdar A, Marini-Bettolo C, Parasuraman D, Spinty S, Willis T, Scoto M, Baranello G, Paediatric UK Risdiplam EAMS Working Group (2024) Risdiplam in spinal muscular atrophy: safety profile and use through the early access to medicine scheme for the paediatric cohort in Great Britain. J Neuromuscul Dis 11(2):361\u2013368. https:\/\/doi.org\/10.3233\/JND-230162","journal-title":"J Neuromuscul Dis"},{"key":"8125_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2022.04.006","volume":"39","author":"J Erdos","year":"2022","unstructured":"Erdos J, Wild C (2022) Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic review of real-world study data. Eur J Paediatr Neurol 39:1\u201310. https:\/\/doi.org\/10.1016\/j.ejpn.2022.04.006","journal-title":"Eur J Paediatr Neurol"},{"key":"8125_CR13","doi-asserted-by":"publisher","unstructured":"Oskoui M, Day JW, Deconinck N, Mazzone ES, Nascimento A, Saito K, Vuillerot C, Baranello G, Goemans N, Kirschner J, Kostera-Pruszczyk A, Servais L, Papp G, Gorni K, Kletzl H, Martin C, McIver T, Scalco RS, Staunton H, Yeung WY, Fontoura P, Mercuri E; SUNFISH Working Group (2023) Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA). J Neurol 270(5):2531\u20132546. https:\/\/doi.org\/10.1007\/s00415-023-11560-1. Epub 2023 Feb 3. Erratum in: J Neurol. 2023 May;270(5):2547\u20132549. https:\/\/doi.org\/10.1007\/s00415-023-11658-6. PMID: 36735057; PMCID: PMC9897618.","DOI":"10.1007\/s00415-023-11560-1"},{"key":"8125_CR14","doi-asserted-by":"publisher","unstructured":"Mercuri E, Deconinck N, Mazzone ES, et al.; SUNFISH Study Group (2022) Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 21(1):42\u201352. https:\/\/doi.org\/10.1016\/S1474-4422(21)00367-7. Erratum in: Lancet Neurol. 2022 Feb;21(2): e2. Erratum in: Lancet Neurol. 2022 Mar;21(3):e3. Erratum in: Lancet Neurol. 2022 May;21(5): e5. PMID: 34942136","DOI":"10.1016\/S1474-4422(21)00367-7"},{"issue":"4","key":"8125_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.clinthera.2024.02.006","volume":"46","author":"R Kantaria","year":"2024","unstructured":"Kantaria R, Baker K, Beckley-Kartey S, Gorni K, Montrocher-Ober I, Vindevoghel L (2024) Global risdiplam compassionate use program for patients with Type 1 or 2 spinal muscular atrophy. Clin Ther 46(4):374\u2013378. https:\/\/doi.org\/10.1016\/j.clinthera.2024.02.006","journal-title":"Clin Ther"},{"issue":"10","key":"8125_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.nmd.2019.08.014","volume":"29","author":"E Mercuri","year":"2019","unstructured":"Mercuri E, Finkel R, Scoto M, iSMAC Group et al (2019) Development of an academic disease registry for spinal muscular atrophy. Neuromuscul Disord 29(10):794\u2013799. https:\/\/doi.org\/10.1016\/j.nmd.2019.08.014","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"8125_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F et al (2018) Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 28(2):103\u2013115. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.005","journal-title":"Neuromuscul Disord."},{"issue":"3","key":"8125_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, SMA Care group et al (2018) Diagnosis and management of spinal muscular atrophy: Part 2 Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 28(3):197\u2013207. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.004","journal-title":"Neuromuscul Disord."},{"issue":"4","key":"8125_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/PEP.0b013e3182351f04","volume":"23","author":"AM Glanzman","year":"2011","unstructured":"Glanzman AM, McDermott MP, Montes J, Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy (PNCR); Muscle Study Group (MSG) et al (2011) Validation of the Children\u2019s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatr Phys Ther Winter 23(4):322\u20136. https:\/\/doi.org\/10.1097\/PEP.0b013e3182351f04","journal-title":"Pediatr Phys Ther Winter"},{"issue":"12","key":"8125_CR20","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1177\/0883073811420294","volume":"26","author":"AM Glanzman","year":"2011","unstructured":"Glanzman AM, O\u2019Hagen JM, McDermott MP, Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy (PNCR); Muscle Study Group (MSG) et al (2011) Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol. 26(12):1499\u2013507. https:\/\/doi.org\/10.1177\/0883073811420294","journal-title":"J Child Neurol."},{"issue":"6","key":"8125_CR21","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/mus.25430","volume":"55","author":"ES Mazzone","year":"2017","unstructured":"Mazzone ES, Mayhew A, Montes J et al (2017) Revised upper limb module for spinal muscular atrophy: Development of a new module. Muscle Nerve 55(6):869\u2013874. https:\/\/doi.org\/10.1002\/mus.25430","journal-title":"Muscle Nerve"},{"issue":"5","key":"8125_CR22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/mus.25120","volume":"54","author":"S Dunaway Young","year":"2016","unstructured":"Dunaway Young S, Montes J, Kramer SS et al (2016) Six-minute walk test is reliable and valid in spinal muscular atrophy. Muscle Nerve 54(5):836\u2013842. https:\/\/doi.org\/10.1002\/mus.25120","journal-title":"Muscle Nerve"},{"issue":"1","key":"8125_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/acn3.51239","volume":"8","author":"RC Sergott","year":"2021","unstructured":"Sergott RC, Amorelli GM, Baranello G, Barreau E, Beres S, Kane S, Mercuri E, Orazi L, SantaMaria M, Tremolada G, Santarsiero D, Waskowska A, Yashiro S, Denk N, F\u00fcrst-Recktenwald S, Gerber M, Gorni K, Jaber B, Jacobsen B, Mueller L, Nave S, Scalco RS, FIREFISH, SUNFISH, JEWELFISH Working Groups (2021) Marzoli SB Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy. Ann Clin Transl Neurol. 8(1):54\u201365. https:\/\/doi.org\/10.1002\/acn3.51239","journal-title":"Ann Clin Transl Neurol."}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08125-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08125-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08125-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:29:05Z","timestamp":1752643745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08125-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8125"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08125-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Albamonte disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Coratti G disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Maggi L disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pegoraro E disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pane M disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Messina S disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Masson R disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D\u2019Amico A disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bertini E disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pini A disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ricci F disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":11,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mongini T disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":12,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bruno C disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":13,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patanella K disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":14,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sframeli M disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":15,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dosi C disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":16,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bonanno S disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":17,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Scarpini G disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":18,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Brolatti N disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":19,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Zanolini A disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":20,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pera MC disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work;","order":21,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mercuri E disclose personal fees from Biogen, Roche, Novartis, Scholar Rock, Epirium, outside of the submitted work;","order":22,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sansone VA disclose personal fees from Biogen, Roche, Novartis, outside of the submitted work.","order":23,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Lizio has nothing to disclose.","order":24,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bravetti C has nothing to disclose.","order":25,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u201cWe confirm that we have read the Journal\u2019s position on issue involved in ethical publication and affirm that this report is consistent with those guidelines.\u201d","order":26,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":27,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent to publish has been obtained from all participants.","order":28,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no conflict of interest.","order":29,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}